Nayara Helisandra Fedrigo

Outbreak of endemic carbapenem-resistant <i>Acinetobacter baumannii</i> in a coronavirus disease 2019 (COVID-19)–specific intensive care unit

Danielle Rosani Shinohara, Sílvia Maria dos Santos Saalfeld, Hilton Vizzi Martinez et al. · Infection Control and Hospital Epidemiology · 2021 · 63 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +16

Pharmacodynamic Evaluation of Fosfomycin against Escherichia coli and Klebsiella spp. from Urinary Tract Infections and the Influence of pH on Fosfomycin Activities

Nayara Helisandra Fedrigo, Josmar Mazucheli, James Albiero et al. · Antimicrobial Agents and Chemotherapy · 2017 · 34 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Pharmacodynamic Effects of Sulbactam/Meropenem/Polymyxin-B Combination Against Extremely Drug Resistant <i>Acinetobacter baumannii</i> Using Checkerboard Information

Thatiany Cevallos Menegucci, Nayara Helisandra Fedrigo, Fernanda Gomes Lodi et al. · Microbial Drug Resistance · 2019 · 31 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

Pharmacodynamic evaluation of suppression of in vitro resistance in Acinetobacter baumannii strains using polymyxin B-based combination therapy

Nayara Helisandra Fedrigo, Danielle Rosani Shinohara, Josmar Mazucheli et al. · Scientific Reports · 2021 · 20 citations · Full text

Medicine, Infectious Diseases, Pharmacology +17

Synergistic activity of polymyxin B combined with vancomycin against carbapenem-resistant and polymyxin-resistant Acinetobacter baumannii: first in vitro study

Danielle Rosani Shinohara, Thatiany Cevallos Menegucci, Nayara Helisandra Fedrigo et al. · Journal of Medical Microbiology · 2019 · 17 citations

Life Sciences, Infectious Diseases, Microbiology +17